Autonomix director granted 13,000 restricted shares

Director Lori Bisson received a 13,000-share restricted stock award in AMIX that vests after one year, increasing her direct holdings to 13,119 shares.

Rhea-AI Filing Summary

Autonomix Medical, Inc. (symbol: AMIX) is the issuer of record for a Form 4 filing submitted to the SEC. Bisson Lori reported acquisition or exercise transactions in this Form 4 filing.

Autonomix Medical, Inc. (AMIX) reported that director Lori Bisson received a grant of 13,000 shares of common stock on September 3, 2026 as a restricted stock award, bringing her direct holdings to 13,119 shares.

The award is scheduled to vest one year from the issuance date, on September 3, 2027. No transactions are reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 13,000 shares

Grant/Award 1 txn

Insider Bisson Lori

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	13,000	--	--

Holdings After Transaction: Common Stock — 13,119 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

Key Figures

Restricted stock award: 13,000 shares Shares owned after award: 13,119 shares Vesting period: 1 year

3 metrics

Restricted stock award 13,000 shares Grant of common stock to director Lori Bisson on September 3, 2026

Shares owned after award 13,119 shares Direct holdings of Lori Bisson following the September 3, 2026 grant

Vesting period 1 year Restricted stock award vests one year from September 3, 2026

Key Terms

restricted stock award, vesting, Rule 10b5-1

3 terms

restricted stock award financial

"Represents restricted stock award vesting one-year from the date of issuance"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

vesting financial

"restricted stock award vesting one-year from the date of issuance"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Rule 10b5-1 regulatory

"No transactions are reported under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AMIX report for director Lori Bisson?

AMIX reported that director Lori Bisson received a grant of 13,000 shares of common stock as a restricted stock award on September 3, 2026, increasing her direct holdings to 13,119 shares after the transaction.

How many AMIX shares does Lori Bisson hold after the reported transaction?

After the award, director Lori Bisson directly holds 13,119 shares of Autonomix Medical, Inc. common stock, according to the ownership reported as of the September 3, 2026 transaction.

When do the newly granted AMIX restricted shares to Lori Bisson vest?

The 13,000-share restricted stock award granted to director Lori Bisson is scheduled to vest one year from the date of issuance, on September 3, 2027.

Was Lori Bisson’s AMIX stock award made under a Rule 10b5-1 plan?

No. The report indicates that the transactions were not made pursuant to a Rule 10b5-1 trading plan, as the related checkbox is not marked as such.

What type of AMIX security was granted to Lori Bisson?

Director Lori Bisson received common stock of Autonomix Medical, Inc. in the form of a restricted stock award totaling 13,000 shares on September 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:21 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:21 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bisson Lori

(Last) (First) (Middle)

21 WATERWAY AVENUE

SUITE 300

(Street)

THE WOODLANDS TEXAS 77380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autonomix Medical, Inc. [ AMIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2026		A		13,000	A	(1)	13,119	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

	/s/ Trent Smith, Attorney-in-Fact for Lori Bisson	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)